UPDATE 1-Forest Labs to buy schizophrenia drug, cut costs

Dec 2 (Reuters) - Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it plans to buy rights to a new schizophrenia treatment from Merck & Co...

from Reuters: Bonds News http://feeds.reuters.com/~r/reuters/bondsNews/~3/sqKG2UZtYig/story01.htm